Literature DB >> 10556922

Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.

E A Harper1, N P Shankley, J W Black.   

Abstract

1 We have investigated the binding of a novel histamine H3-receptor antagonist radioligand, [3H]- clobenpropit ([3H]-VUF9153), to guinea-pig cerebral cortex membranes. 2 Saturation isotherms for [3H]-clobenpropit appeared biphasic. Scatchard plots were curvilinear and Hill plot slopes were significantly less than unity (0.63+/-0.03; n = 12+/-s.e.mean). The radioligand appeared to label two sites in guinea-pig cerebral cortex membranes with apparent affinities (pKD') of 10.91+/-0.12 (Bmax = 5.34+/-0.85 fmol mg(-1) original wet weight) and 9.17+/-0.16 (Bmax = 23.20+/-6.70 fmol mg(-1)). 3 In the presence of metyrapone (3 mM) or sodium chloride (100 mM), [3H]-clobenpropit appeared to label a homogeneous receptor population (Bmax=3.41+/-0.46 fmol mg-1 and 3.49+/-0.44 fmol mg(-1), pKD' = 10.59+/-0.17 and 10.77+/-0.02, respectively). Scatchard plots were linear and Hill slopes were not significantly different from unity (0.91+/-0.04 and 0.99+/-0.02, respectively). Granisetron (1 microM), rilmenidine (3 microM), idazoxan (0.3 microM), pentazocine (3 microM) and 1,3-di-(2-tolyl)guanidine (0.3 microM) had no effect on the binding of [3H]-clobenpropit. 4 The specific binding of [3H]-clobenpropit appeared to reach equilibrium after 25 min at 21+/-3 degrees C and remained constant for >180 min. The estimated pKD' (10.27+/-0.27; n = 3+/-s.e.mean) was not significantly different from that estimated by saturation analysis in the presence of metyrapone. 5 A series of histamine H3-receptor ligands expressed affinity values for sites labelled with [3H]-clobenpropit which were not significantly different from those estimated when [3H]-R-alpha-MH was used to label histamine H3-receptors in guinea-pig cerebral cortex membranes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556922      PMCID: PMC1571704          DOI: 10.1038/sj.bjp.0702860

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Purification of 5-hydroxytryptamine3 receptors from porcine brain.

Authors:  S Fletcher; N M Barnes
Journal:  Br J Pharmacol       Date:  1997-10       Impact factor: 8.739

2.  A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data.

Authors:  R S Kent; A De Lean; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

3.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

4.  Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.

Authors:  R Leurs; M Kathmann; R C Vollinga; W M Menge; E Schlicker; H Timmerman
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

5.  Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues.

Authors:  K Yanai; J H Ryu; N Sakai; T Takahashi; R Iwata; T Ido; K Murakami; T Watanabe
Journal:  Jpn J Pharmacol       Date:  1994-06

6.  Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.

Authors:  C Gargalidis-Moudanos; A Parini
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

7.  Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.

Authors:  R Leurs; M T Tulp; W M Menge; M J Adolfs; O P Zuiderveld; H Timmerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.

Authors:  T Hiroi; N Ohishi; S Imaoka; Y Yabusaki; H Fukui; Y Funae
Journal:  J Pharmacol Exp Ther       Date:  1995-02       Impact factor: 4.030

9.  [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.

Authors:  H Stark; K Purand; A Hüls; X Ligneau; M Garbarg; J C Schwartz; W Schunack
Journal:  J Med Chem       Date:  1996-03-15       Impact factor: 7.446

10.  Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Authors:  E Schlicker; M Kathmann; S Reidemeister; H Stark; W Schunack
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more
  6 in total

1.  Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.

Authors:  David G Witte; Betty Bei Yao; Thomas R Miller; Tracy L Carr; Steven Cassar; Rahul Sharma; Ramin Faghih; Bruce W Surber; Timothy A Esbenshade; Arthur A Hancock; Kathleen M Krueger
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.

Authors:  J A Arias-Montaño; B Floran; M Garcia; J Aceves; J M Young
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Histamine H3-receptor agonists and imidazole-based H3-receptor antagonists can be thermodynamically discriminated.

Authors:  E A Harper; J W Black
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

4.  Correlation of apparent affinity values from H3-receptor binding assays with apparent affinity (pKapp) and intrinsic activity (alpha) from functional bioassays.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

5.  Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

6.  Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.

Authors:  Guadalupe-Elide Morales-Figueroa; Ricardo Márquez-Gómez; Raúl González-Pantoja; Juan Escamilla-Sánchez; José-Antonio Arias-Montaño
Journal:  ACS Chem Neurosci       Date:  2014-06-11       Impact factor: 4.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.